Sartorius (SRT3) Given a €78.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €78.00 ($92.86) price target on Sartorius (FRA:SRT3) in a research note released on Thursday. The brokerage currently has a neutral rating on the stock.

Several other brokerages have also issued reports on SRT3. UBS Group set a €85.00 ($101.19) price target on shares of Sartorius and gave the company a neutral rating in a report on Tuesday, October 17th. Deutsche Bank set a €80.00 ($95.24) price target on shares of Sartorius and gave the company a neutral rating in a report on Friday, December 1st. Nord/LB set a €70.00 ($83.33) price target on shares of Sartorius and gave the company a sell rating in a report on Tuesday, October 17th. Warburg Research set a €100.00 ($119.05) price target on shares of Sartorius and gave the company a buy rating in a report on Tuesday, October 17th. Finally, Berenberg Bank set a €90.00 ($107.14) price target on shares of Sartorius and gave the company a buy rating in a report on Wednesday, September 20th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of Hold and an average price target of €78.40 ($93.33).

Shares of Sartorius (FRA:SRT3) opened at €84.65 ($100.77) on Thursday. The stock has a market cap of $6,080.00 and a P/E ratio of 68.82. Sartorius has a 1-year low of €63.72 ($75.86) and a 1-year high of €94.00 ($111.90).

TRADEMARK VIOLATION WARNING: This piece of content was reported by Equities Focus and is the property of of Equities Focus. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.equitiesfocus.com/2018/01/08/sartorius-srt3-given-a-78-00-price-target-at-kepler-capital-markets.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply